The Global Reach of FTC v. Actavis – Will Europe Differ from the US Approach to Pay-for-Delay Agreements?
暂无分享,去创建一个
[1] Wolfgang Kerber,et al. Patent Settlements in the Pharmaceutical Industry: An Antitrust Perspective , 2013 .
[2] I. Lianos,et al. New challenges in the intersection of intellectual property rights with competition law: a view from Europe and the United States , 2013 .
[3] Thomas K. Cheng. Putting Innovation Incentives Back in the Patent-Antitrust Interface , 2013 .
[4] E. Elhauge,et al. Solving the Patent Settlement Puzzle , 2012 .
[5] Pablo Ibáñez Colomo. Market failures, transaction costs and article 101(1) TFEU case law , 2012 .
[6] Michael A. Carrier. Why the 'Scope of the Patent' Test Cannot Solve the Drug Patent Settlement Problem , 2012 .
[7] O. Gurgula. Restrictive Practices in the Pharmaceutical Industry: Reverse Payment AgreementsSeeking for a Balance between Intellectual Property and Competition Law , 2012 .
[8] P. Larouche,et al. Does Europe Have an Innovation Policy? The Case of EU Economic Law , 2011 .
[9] Joshua P. Davis. Applying Litigation Economics to Patent Settlements: Why Reverse Payments Should be Per Se Illegal , 2009 .
[10] Pablo Cortés. An Analysis of Offers to Settle in Common Law Courts: Are They Relevant in the Civil Law Context? , 2009 .
[11] Michael A. Carrier. Unsettling drug patent settlements: a framework for presumptive illegality. , 2009, Michigan law review.
[12] Josef Drexl. "Pay-for-Delay" and Blocking Patents - Targeting Phamaceutical Companies under European Competition Law , 2009 .
[13] A. Reindl. Resale Price Maintenance and Article 101: Developing a More Sensible Analytical Approach , 2009 .
[14] C. Hemphill. Paying for Delay: Pharmaceutical Patent Settlement as a Regulatory Design Problem , 2006 .
[15] Mark D. Janis,et al. Anticompetitive Settlement of Intellectual Property Disputes , 2003 .
[16] Mark Gidley. The U.S. FTC publishes a report on generic drug entry prior to patent expiration raising issues on patent-shortening settlement agreements , 2002 .